Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis
AssigneeSanofi-Aventis U.S. LLC
InventorsWilliam BYRNES, Patrice DOUILLET, Gerald FRANGIN
Life of this patent
Estimating the term…
Abstract
This invention is related to the use of the combination of teriflunomide and interferon beta thereof, for the preparation of a medicament for use in treating multiple sclerosis.
Claims15
A method for treating relapsing-remitting form of multiple sclerosis, in a patient in need thereof, comprising administering to the patient about 7 mg or about 14 mg teriflunomide, and a pharmaceutically effective amount of interferon beta-1a or 1b.
A method for reducing the number of T1-Gd lesions in a patient afflicted with relapsing-remitting form of multiple sclerosis comprising administering to the patient about 7 mg or about 14 mg teriflunomide, and a pharmaceutically effective amount of interferon beta-1a or 1b.
A method for reducing the volume of T1-Gd lesions in a patient afflicted with relapsing-remitting form of multiple sclerosis, comprising administering to the patient about 7 mg or about 14 mg teriflunomide once a day, and a stable dose of interferon beta-1a or 1b.
Dependencies are inferred from the claim text.